elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34408990-7A49FE12-E80D-4976-A752-1A1A633736E7
Q34408990-7A49FE12-E80D-4976-A752-1A1A633736E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34408990-7A49FE12-E80D-4976-A752-1A1A633736E7
Predicting response to Anti-TNF Agents for the treatment of crohn's disease.
P2860
Q34408990-7A49FE12-E80D-4976-A752-1A1A633736E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34408990-7A49FE12-E80D-4976-A752-1A1A633736E7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
49845f32778c939e65d1c1685c5f2b94269926b5
P2860
Risks and benefits of infliximab for the treatment of Crohn's disease